The release of Alzheimer's disease beta amyloid peptide is reduced by phorbol treatment.

This publication has 45 references indexed in Scilit:

• Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway.
  The Journal of cell biology, 1993
• Secretion of the β‐Amyloid Precursor Protein^a
  Annals of the New York Academy of Sciences, 1992
• Secretory processing of the Alzheimer amyloid βA4 protein precursor is increased by protein phosphorylation
  Biochemical and Biophysical Research Communications, 1992
• α2‐Macroglobulin and other proteinase inhibitors do not interfere with the secretion of amyloid precursor protein in mouse neuroblastoma cells
  FEBS Letters, 1992
• Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor
  Science, 1992
• Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins
  Biochemistry, 1991
• Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
  Science, 1990
• Regulation of mannose 6‐phosphate/insulin‐like growth factor II receptor distribution by activators and inhibitors of protein kinase C
  European Journal of Biochemistry, 1990
• Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein
  Biochemical and Biophysical Research Communications, 1989
• Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms
  Cell, 1986